Hyderabad, February 12 Biological E Limited announced on Thursday that the WHO has granted phase II pre-qualification for its Novel Oral Polio Vaccine type 2.Phase II pre-qualification covers both the drug substance and the drug product manufactured at BE, completing the full manufacturing...
biological e limited
circulating vaccine-derived poliovirus type 2 (cvdpv2)
novel oral poliovaccine type 2
poliovaccinevaccine manufacturing
who pre-qualification
Kolkata, February 10 Oral polio vaccines (OPVs) are safe, effective, and crucial for global eradication efforts, but there is a need for improved immunization to combat the emergence of vaccine-derived poliovirus strains, a US-based public health expert said.Referring to India's current...